1. A dynamic nanoconfinement strategy towards self-healing soft electronics with super stretchability, ultrahigh strength and reliably high conductivity. Issue 39 (21st September 2022) Authors: Wang, Jun-Peng; Fu, Chuhan; Wu, Zehua; Lan, Hao; Cui, Siwen; Qi, Tao Journal: Journal of materials chemistry Issue: Volume 10:Issue 39(2022) Page Start: 21093 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trial. (July 2022) Authors: Cheng, Yi; Wu, Zehua; Shi, Lishuo; Shen, Cailu; Zhang, Jianwei; Hu, Huabin; Li, Weiwei; Cai, Yue; Xie, Xiaoyu; Ling, Jiayu; Zheng, Qin; Deng, Yanhong Journal: EClinicalMedicine Issue: Volume 49(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comprehensive analysis of spectral distribution of a large cohort of Chinese patients with non‐syndromic oculocutaneous albinism facilitates genetic diagnosis. (29th May 2019) Authors: Zhong, Zilin; Gu, Li; Zheng, Xiujie; Ma, Nengjun; Wu, Zehua; Duan, Juan; Zhang, Jun; Chen, Jianjun Journal: Pigment cell & melanoma research Issue: Volume 32:Number 5(2019) Page Start: 672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Corrigendum to "Overexpression of GRK3, Promoting Tumor Proliferation, Is Predictive of Poor Prognosis in Colon Cancer". (23rd October 2020) Authors: Jiang, Tao; Yang, Chun; Ma, Liyuan; Wu, Zehua; Ye, Ling; Ma, Xiaoqiang; Li, Hai; Fan, Junwei; Yang, Yinxue Journal: Disease markers Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Does auditory numerosity and non-numerical magnitude affect visual non-symbolic numerical representation?. (January 2023) Authors: Wu, Zehua; Zhang, Jinbo; Wu, Jiashuang; Mou, Yi; Yue, Zhenzhu Journal: Perception Issue: Volume 52:Number 1(2023) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Fused silica with sub‐angstrom roughness and minimal surface defects polished by ultrafine nano‐CeO2. Issue 3 (24th November 2022) Authors: Wu, Zehua; Zhang, Zhixin; Jia, Yong; Teng, Fei; Li, Gang; Wang, Feng; Jin, Yuqi Journal: Journal of the American Ceramic Society Issue: Volume 106:Issue 3(2023) Page Start: 1766 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Identification of immune cell infiltration landscape for predicting prognosis of colorectal cancer. (11th April 2023) Authors: Wu, Xueqian; Li, Jianxia; Zhang, Yuanzhe; Cheng, Yi; Wu, Zehua; Zhan, Weixiang; Deng, Yanhong Journal: Gastroenterology report Issue: Volume 11(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. In‐situ observation of electrical tree evolution in epoxy dielectrics with internal cracks. Issue 2 (27th October 2020) Authors: Wu, Zehua; Tian, Huidong; Zhu, Sijia; Li, He; Wang, Qingyu; Xie, Zongliang; Liu, Peng; Peng, Zongren Journal: High voltage Issue: Volume 6:Issue 2(2021) Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MicroRNA‐766 promotes cancer progression by targeting NR3C2 in hepatocellular carcinoma. Issue 1 (21st August 2018) Authors: Yang, Chao; Ma, Xiang; Guan, Ge; Liu, Huan; Yang, Yuling; Niu, Qinghui; Wu, Zehua; Jiang, Yueping; Bian, Cheng; Zang, Yunjin; Zhuang, Likun Journal: FASEB journal Issue: Volume 33:Issue 1(2019) Page Start: 1456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild‐Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial. (3rd September 2020) Authors: Hu, Huabin; Wang, Kun; Huang, Meijin; Kang, Liang; Wang, Wei; Wang, Hui; Qiu, Meng; Lin, Rongbo; Zhang, Haibo; Lan, Ping; Wu, Xiaojian; Liu, Guangjian; Wan, Yunle; Liu, Ming; Zhou, Zhiyang; Huang, Yan; Li, Fangqian; Zhang, Jianwei; Cai, Yue; Ma, Tenghui Journal: Oncologist Issue: Volume 26:Number 1(2021) Page Start: e90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗